Oxaliplatin plus leucovorin and 5-fluorouracil (FOLFOX-4) as a salvage chemotherapy in heavily-pretreated platinum-resistant ovarian cancer

Abstract Background The purpose of this study was to evaluate the clinical impact of oxaliplatin, leucovorin, and 5-fluorouracil (FOLFOX-4) chemotherapy in terms of the response rate, progression-free/overall survival (PFS/OS) and safety profile in patients with heavily pretreated recurrent epitheli...

وصف كامل

التفاصيل البيبلوغرافية

المؤلفون الرئيسيون:	Vincenza Conteduca, Giorgia Gurioli, Lorena Rossi, Emanuela Scarpi, Cristian Lolli, Giuseppe Schepisi, Alberto Farolfi, Delia De Lisi, Valentina Gallà, Salvatore Luca Burgio, Cecilia Menna, Andrea Amadori, Lorena Losi, Dino Amadori, Maria Paola Costi, Ugo De Giorgi
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	BMC 2018-12-01
سلاسل:	BMC Cancer
الموضوعات:	FOLFOX-4 Fluorouracil Topotecan Ovarian cancer Platinum resistance Survival
الوصول للمادة أونلاين:	http://link.springer.com/article/10.1186/s12885-018-5180-1
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!